x
African Health Sciences
[contact-form-7 id="2459" title="Sidebar Form"]

  • 256(41)530021
  • info@africanhealthsciences.org
African Health Sciences
  • info@africanhealthsciences.org
  • Give Feedback
  • Home
  • About Us
  • Staff
  • Focus & Scope
  • For Authors
  • More Links
    • About The Journal
    • Latest Articles
    • Journal Archives
    • Our Events
    • Faq’s
  • Contact Us
Logo

Contact Info

  • P. O. Box 7072 Kampala, Uganda
  • +256(41)530021
  • info@africanhealthsciences.org
  • ISSN 1680-6905
  • <!--
  • -->

02Jan2018

Prevalence of mecA gene among staphylococci

by admin,  0 Comments

Prevalence of mecA gene among staphylococci from clinical samples of a tertiary hospital in Benin City, Nigeria.

Ephraim Ehidiamen Ibadin1, Idahosa Onaiwu Enabulele2, Fowora Muinah3
1. Medical Microbiology Unit, Medical Laboratory Services, University of Benin Teaching Hospital,
Benin City, Nigeria.
2. Department of Microbiology, Faculty of Life Sciences, University of Benin, Benin City, Nigeria.
3. Molecular Biology and Biotechnology Division, Nigerian Institute of Medical Research, Yaba, Nigeria.


Abstract
Background: The staphylococci have increasingly been associated with infections worldwide and anti-microbial resistance has
made these versatile pathogens more recalcitrant in the hospital setting.

Objectives: This study sought to investigate the occurrence and distribution of Staphylococcus species as well as determine the
prevalence of methicillin resistant
Staphylococcus aureus (MRSA) and methicillin resistant coagulase negative staphylococci (MRCoNS)
among clinical samples from University of Benin Teaching Hospital (UBTH) in Benin City.

Methods: Ninety one (91) clinical isolates comprising S. aureus and Coagulase Negative staphylococci (CoNS) were recovered from
routine clinical specimens and anti-microbial susceptibility tests were carried out. Polymerase Chain Reaction (PCR) was thereafter carried out on these isolates to detect
mecA gene.

Results: Staphylococcus species had its highest prevalence from infected wounds of patients (28.8%) while urine samples showed
the least (5.4%). The highest level of resistance was to ceftazidime (
S. aureus – 68%, CoNS – 75.6%) while the least resistancenwas observed for meropenem (S. aureus– 26%, CoNS- 46.3%). Using phenotypic method (with 1µg oxacillin antibiotic disc), the distribution of MRSA and MRCoNS was 44.0% and 46.3% respectively. PCR analysis showed that 38.0% of S. aureus and 41.5%  of the CoNS had mecA gene respectively; wound swabs showed the highest prevalence with 30.5% of staphylococcal isolates being mecA gene positive. There was also no signifcant association between the Staphylococcal isolates and their isolation rate, isolation site and mecA gene distribution (p > 0.05).

Conclusion: This study draws attention on the increase in the prevalence of mecA gene (39.6%) and an increase in multidrug
resistant
staphylococci when compared to previous studies in our country; it recommends laboratory guidance and periodic review
to stem the tide of resistance.

Keywords: Staphylococcus aureus (S. aureus), coagulase-negative staphylococci (CoNS), mecA gene, methicillin-resistance.

Related posts:

Polymerase chain reaction to search for Herpes viruses

Developmental screening: predictors of follow-up adherence in primary health care.

Vitamin B 6 and homocysteine levels in carbamazepine treated epilepsy of Khyber Pakhtunkhwa.

Recent Posts

  • Editor’s choice: Tackling infectious diseases, NCDs and sexual reproductivehealth issues as we enter our 24th year of remarkable growth
  • Preconception and contraceptive care for women living with HIV/AIDSattending antiretroviral treatment clinics in Lagos State, Nigeria
  • Effects of SNPs on TNF-α and IL-10 cytokine expression in TB and HIVpatients in the Capricorn district, Limpopo Province, South Africa
  • Prevalence of Schistosomiasis in a neglected community, South western Nigeria at two points in time, spaced three years apart
  • Review of Leishmaniasis in the Middle East and North Africa

Recent Comments

No comments to show.

Archives

  • April 2024
  • May 2019
  • April 2019
  • September 2018
  • August 2018
  • January 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017

Categories

  • 2001 Issues
  • 2002 Issues
  • 2003 Issues
  • 2004 Issues
  • 2005 Issues
  • 2006 Issues
  • 2007 Issues
  • 2008 Issues
  • 2009 Issues
  • 2010 Issues
  • 2011 Issues
  • 2012 Issues
  • 2013 Issues
  • 2014 Issues
  • 2015 Issues
  • 2016 Issues
  • 2017 Issues
  • 2018 Issues
  • 2019 Issues
  • 2024 Issues
  • Articles
  • December issue
  • December Release
  • June Issue
  • June Release
  • March Issue
  • March Issue
  • March Release
  • News
  • number / volume 2
  • number /volume 1
  • number /volume 1
  • number /volume 1 2008
  • number 1
  • number 1
  • number 1
  • number 1
  • number 1
  • number 1
  • number 1
  • number 2
  • number 2
  • number 2
  • number 2
  • number 2
  • number 2
  • number 2
  • number 2 special Issue
  • number 2 special Issue 2
  • number 3
  • number 3
  • number 3
  • number 3
  • number 3
  • number 3
  • number 3
  • number 4
  • number 4
  • number 4
  • number 4
  • number 4
  • number 4
  • number/ volume 3 2008
  • number/ volume 4 2008
  • number/volume 1
  • number/volume 1
  • number/volume 2
  • number/volume 2
  • number/volume 2 2008
  • number/volume 3
  • number/volume 3
  • number/volume 3
  • number/volume 4
  • number/volume1
  • September Issue
  • September Release
  • Special Edition
  • special Issue
  • Uncategorized
  • Vol. 24 No. 1 (2024)
  • volume 1
  • volume 1
  • volume 1
  • volume 2
  • volume 2
  • volume 2
  • volume 2
  • volume 2
  • volume 3
  • volume 3
  • volume 3
  • volume 3
  • volume 4
  • volume 4
  • volume 4
  • volume 4
  • volume1

Categories

  • 2001 Issues
  • 2002 Issues
  • 2003 Issues
  • 2004 Issues
  • 2005 Issues
  • 2006 Issues
  • 2007 Issues
  • 2008 Issues
  • 2009 Issues
  • 2010 Issues
  • 2011 Issues
  • 2012 Issues
  • 2013 Issues
  • 2014 Issues
  • 2015 Issues
  • 2016 Issues
  • 2017 Issues
  • 2018 Issues
  • 2019 Issues
  • 2024 Issues
  • Articles
  • December issue
  • December Release
  • June Issue
  • June Release
  • March Issue
  • March Issue
  • March Release
  • News
  • number / volume 2
  • number /volume 1
  • number /volume 1
  • number /volume 1 2008
  • number 1
  • number 1
  • number 1
  • number 1
  • number 1
  • number 1
  • number 1
  • number 2
  • number 2
  • number 2
  • number 2
  • number 2
  • number 2
  • number 2
  • number 2 special Issue
  • number 2 special Issue 2
  • number 3
  • number 3
  • number 3
  • number 3
  • number 3
  • number 3
  • number 3
  • number 4
  • number 4
  • number 4
  • number 4
  • number 4
  • number 4
  • number/ volume 3 2008
  • number/ volume 4 2008
  • number/volume 1
  • number/volume 1
  • number/volume 2
  • number/volume 2
  • number/volume 2 2008
  • number/volume 3
  • number/volume 3
  • number/volume 3
  • number/volume 4
  • number/volume1
  • September Issue
  • September Release
  • Special Edition
  • special Issue
  • Uncategorized
  • Vol. 24 No. 1 (2024)
  • volume 1
  • volume 1
  • volume 1
  • volume 2
  • volume 2
  • volume 2
  • volume 2
  • volume 2
  • volume 3
  • volume 3
  • volume 3
  • volume 3
  • volume 4
  • volume 4
  • volume 4
  • volume 4
  • volume1

Archives

  • April 2024
  • May 2019
  • April 2019
  • September 2018
  • August 2018
  • January 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017

Tags

Achives Latest News


ISSN 1680-6905

  • P. O. Box 7072 ,Kampala, Uganda
  • Call Us: 256(41)530021
  • info@africanhealthsciences.org

Latest Activities

Usefull Link

  • About AHS
  • Services
  • Focus & Scope
  • Our Articles
  • Contact Us

Subscribe

For research updates from African Health Sciences, sign up now!

[contact-form-7 id="1620" title="Subscribe"]

African Health Sciences © All Right Reserved